The Patent Finder
US

Immunoglobulin Chimeric Monomer-Dimer Hybrids

US 9,636,416 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended May 6, 2024 · High confidence

USPTO later recorded it as expired for non-payment on Jun 9, 2025.

Filed Oct 31, 2014 as application 14/530,256 · Granted May 2, 2017
Base term, 20 years from filing
Today
20 years from filing
Term ended May 6, 2024
2004 2026
Clock starts
May 6, 2004
Term ended
May 6, 2024
Granted
May 2, 2017
base term after the term ends fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,381,408, US 7,820,162, to May 6, 2024. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
12
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 6, 2004, when application 10/841,250, the earliest non-provisional in its chain, was filed (this one was filed Oct 31, 2014)May 6, 2024High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,381,408, US 7,820,162)resolves to May 6, 2024, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 1 maintenance fees paidterm endedHigh confidence
USPTO status recordRecorded as expired for non-payment on Jun 9, 2025, after the term endedno changeHigh confidence
Computed term endThe steps above, in orderMay 6, 2024High confidence

This family

US 7,404,956In force
Jun 2028
Jun 2028
US 7,348,004In force
Mar 2028
Mar 2028
Application PCT/US2006/000140PCT application
no patent term
no patent term
US 7,862,820Term ended
no later than Mar 2026
no later than Mar 2026
US 8,329,182Term ended
no later than May 2024
no later than May 2024
US 8,932,830Term ended
May 2024
May 2024
US 9,636,416this patent
May 2024
May 2024
US 11,401,322Term ended
May 2024
May 2024
8 of 12 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 31, 2015
Reel 34870, frame 234
Syntonix Pharmaceuticals, Inc.Biogen Idec Hemophilia Inc.Change of Name
Mar 16, 2015
Reel 35168, frame 825
Peters, Robert T.; Mezo, Adam R.; Rivera, Daniel S.; Bitonti, Alan J.; Low, Susan C.Syntonix Pharmaceuticals, Inc.Assignment of Assignor's Interest
Apr 30, 2015
Reel 35553, frame 325
Biogen Idec Hemophilia Inc.Biogen Hemophilia Inc.Change of Name
Jul 2, 2015
Reel 36051, frame 773
Biogen Hemophilia Inc.Biogen Hemophilia Inc.Change of Address
Feb 16, 2017
Reel 41735, frame 621
Biogen Hemophilia Inc.Bioverativ Therapeutics Inc.Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited